Double maintains 1 strategies that include SRDX - Surmodics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNUT | 0.01% | $548.27M | -73.07% | 4.37% |
WOOF | -0.02% | $879.15M | +28.86% | 0.00% |
HTZ | 0.02% | $896.79M | +14.31% | 0.00% |
GORV | -0.02% | $15.42M | -96.17% | 0.00% |
LVO | 0.03% | $86.47M | -50.28% | 0.00% |
BULL | -0.03% | $5.67B | +11.22% | 0.00% |
ERJ | -0.04% | $9.06B | +64.69% | 0.00% |
DOGZ | 0.05% | $231.95M | +120.05% | 0.00% |
EXR | 0.08% | $31.53B | -1.83% | 4.36% |
KO | -0.09% | $308.23B | +13.09% | 2.75% |
NEOG | -0.09% | $1.42B | -51.08% | 0.00% |
HALO | -0.10% | $6.03B | +7.84% | 0.00% |
INVH | -0.10% | $20.86B | -3.35% | 3.35% |
WSO | 0.10% | $19.41B | +1.81% | 2.30% |
LW | 0.10% | $7.31B | -40.44% | 2.82% |
CATX | -0.10% | $178.89M | -84.25% | 0.00% |
TRMD | -0.12% | $1.74B | -53.07% | 28.35% |
JOYY | 0.14% | $1.52B | +24.98% | 2.21% |
O | -0.14% | $50.03B | +0.38% | 5.73% |
FYBR | -0.16% | $9.16B | +36.87% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | 0.01% | $173.44M | 0.5% |
IAGG | 0.04% | $7.30B | 0.07% |
BUXX | 0.06% | $284.43M | 0.25% |
IBMS | -0.08% | $69.47M | 0.18% |
UUP | -0.11% | $292.27M | 0.77% |
FMHI | 0.11% | $757.44M | 0.7% |
UTEN | 0.12% | $192.72M | 0.15% |
FLGV | -0.13% | $976.63M | 0.09% |
CCOR | 0.16% | $59.79M | 1.18% |
IEF | 0.22% | $34.17B | 0.15% |
FLIA | -0.32% | $670.20M | 0.25% |
BSSX | 0.34% | $75.11M | 0.18% |
IBTO | -0.35% | $330.69M | 0.07% |
BSCP | 0.37% | $3.49B | 0.1% |
TBLL | -0.52% | $2.46B | 0.08% |
BSMR | 0.52% | $245.57M | 0.18% |
FXE | -0.62% | $525.40M | 0.4% |
DUSB | 0.63% | $1.20B | 0.15% |
TFLO | 0.64% | $7.06B | 0.15% |
TOTL | 0.70% | $3.59B | 0.55% |
Current Value
$27.991 Year Return
Current Value
$27.991 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EFAA | 30.08% | $150.50M | 0.39% |
RSPA | 29.40% | $319.03M | 0.29% |
CPRJ | 28.62% | $48.43M | 0.69% |
QQA | 28.38% | $225.66M | 0.29% |
CPNJ | 27.91% | $27.56M | 0.69% |
AIPI | 27.51% | $288.11M | 0.65% |
XHE | 27.29% | $171.93M | 0.35% |
IGBH | 27.21% | $97.62M | 0.14% |
PAWZ | 26.37% | $58.77M | 0.5% |
ETH | 26.11% | $1.13B | 0% |
ETHA | 26.09% | $3.38B | 0.25% |
FETH | 25.98% | $1.08B | 0.25% |
ETHV | 25.95% | $123.08M | 0% |
QETH | 25.87% | $22.91M | 0.25% |
ETHW | 25.81% | $250.22M | 0% |
EZET | 25.81% | $34.72M | 0% |
CETH | 25.79% | $24.05M | 0% |
UOCT | 25.77% | $211.52M | 0.79% |
BTC | 25.67% | $4.48B | 0.15% |
HYEM | 25.51% | $378.22M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -21.27% | $140.49M | 0.59% |
VIXY | -16.91% | $109.64M | 0.85% |
BTAL | -15.63% | $361.41M | 1.43% |
IVOL | -14.91% | $353.94M | 1.02% |
CLIP | -13.04% | $1.50B | 0.07% |
FTSD | -12.18% | $212.46M | 0.25% |
SGOV | -10.40% | $45.91B | 0.09% |
XONE | -10.03% | $603.24M | 0.03% |
BSMW | -9.68% | $102.62M | 0.18% |
BILS | -9.61% | $3.96B | 0.1356% |
SPTS | -8.57% | $5.76B | 0.03% |
SHYM | -8.17% | $322.93M | 0.35% |
KCCA | -7.50% | $97.18M | 0.87% |
STPZ | -7.41% | $446.46M | 0.2% |
IBTI | -7.01% | $995.39M | 0.07% |
XBIL | -6.50% | $782.40M | 0.15% |
UTWO | -6.42% | $387.71M | 0.15% |
IBTH | -6.21% | $1.53B | 0.07% |
TBIL | -5.81% | $5.76B | 0.15% |
NEAR | -5.49% | $3.26B | 0.25% |
Yahoo
Investors need to pay close attention to SRDX stock based on the movements in the options market lately.
Yahoo
Despite the strength in Pounce thrombectomy device platforms and strong IVD product sales, Surmodics' second-quarter fiscal 2025 results show weak performance.
Yahoo
The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Yahoo
SurModics (SRDX) delivered earnings and revenue surprises of -116.67% and 8.73%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
SRDX) on Wednesday reported a loss of $5.2 million in its fiscal second quarter. On a per-share basis, the Eden Prairie, Minnesota-based company said it had a loss of 36 cents. Losses, adjusted for costs related to mergers and acquisitions and amortization costs, came to 13 cents per share.
Yahoo
EDEN PRAIRIE, Minn., April 30, 2025--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2025, and introduced its financial guidance for the fiscal year ending September 30, 2025.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALHC | -15.43% | $2.95B | +113.16% | 0.00% |
NAT | -14.59% | $575.96M | -36.00% | 12.41% |
PTGX | -13.44% | $2.75B | +39.04% | 0.00% |
CME | -13.11% | $98.74B | +28.80% | 3.84% |
MSEX | -12.35% | $1.02B | -1.01% | 2.34% |
CREG | -11.80% | $16.80M | -32.73% | 0.00% |
FMTO | -11.70% | $45.74M | -99.96% | 0.00% |
RCKY | -11.31% | $155.86M | -44.63% | 2.97% |
ELV | -11.18% | $88.11B | -28.29% | 1.68% |
MOH | -10.19% | $17.02B | -8.99% | 0.00% |
CBOE | -10.13% | $22.95B | +20.67% | 1.12% |
PSTL | -10.07% | $319.60M | -2.76% | 7.23% |
AFCG | -9.98% | $118.86M | -35.93% | 26.00% |
BMO | -9.85% | $74.92B | +8.84% | 4.36% |
MKTX | -9.60% | $8.01B | -1.42% | 1.39% |
TU | -9.54% | $23.77B | -4.62% | 7.19% |
UNH | -9.21% | $248.87B | -47.37% | 3.06% |
AGL | -8.73% | $1.06B | -54.30% | 0.00% |
CNC | -8.70% | $29.89B | -22.14% | 0.00% |
ODD | -8.54% | $2.80B | +45.07% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NABL | 44.85% | $1.54B | -36.63% | 0.00% |
ANF | 41.42% | $3.79B | -41.29% | 0.00% |
ASTS | 40.17% | $6.27B | +551.12% | 0.00% |
CHWY | 39.76% | $17.15B | +144.37% | 0.00% |
DKS | 37.66% | $14.33B | -9.07% | 2.50% |
SW | 30.73% | $24.34B | +0.89% | 2.25% |
DELL | 28.83% | $77.37B | -24.22% | 1.66% |
BCSF | 28.82% | $1.01B | -4.23% | 10.80% |
LINE | 27.30% | $10.81B | -39.36% | 3.02% |
SON | 26.83% | $4.52B | -23.64% | 4.57% |
DMRC | 26.37% | $289.87M | -46.16% | 0.00% |
MOMO | 26.23% | $768.25M | +8.00% | 0.00% |
RBBN | 25.92% | $639.09M | +10.70% | 0.00% |
EIX | 25.72% | $22.16B | -24.07% | 5.55% |
REPX | 25.68% | $611.14M | +8.14% | 5.37% |
GEF | 25.44% | $3.28B | -12.20% | 3.80% |
VICR | 24.87% | $1.95B | +28.42% | 0.00% |
ALGN | 24.49% | $13.53B | -31.74% | 0.00% |
ECPG | 24.40% | $954.28M | -12.30% | 0.00% |
OLN | 24.00% | $2.43B | -62.61% | 3.79% |